DPP4 and hydrops fetalis: In the secondary analysis on hospitalisations for HF, patients on SGLT2 inhibitors were less likely to be hospitalised compared to DPP4 inhibitor initiators (RR 0.78; 95% CI 0.63, 0.95) (Table 4).